Comparison of Clinicopathologic Characteristics and Survival Outcome Between Invasive Papillary Carcinoma and Invasive Ductal Carcinoma
ABSTRACT Introduction Invasive papillary carcinoma (IPC) of the breast is an exceptionally rare histological subtype. This study compared the clinicopathological characteristics, biomarker expression profiles and survival outcomes of IPC with those of invasive ductal carcinoma of no special type (IDC‐NST). Materials and Methods The medical records of 6599 patients treated at the Breast Disease Research Center between December 1993 and December 2021 were retrospectively reviewed. Patients were categorized into IPC ( n = 27) and IDC ( n = 6572) groups. Tumour size, axillary lymph node status, pathologic stage, histologic grade, hormone receptor status (ER, PR), HER2 status, surgical management, adjuvant therapies and survival outcomes were analysed and compared. Survival distributions were evaluated using Kaplan–Meier curves and compared using the log‐rank test. Results Patients with IPC were significantly older at presentation than those with IDC (mean age: 58.5 ± 14.0 vs. 49.0 ± 12.4 years, p = 0.02). Compared with IDC, IPC tumours demonstrated significantly less aggressive features, including a lower rate of axillary lymph node involvement (14.8% vs. 39.2%, p < 0.001) and a lower incidence of lymphovascular invasion (14.9% vs. 53.3%, p < 0.001). IPC tumours were predominantly low‐grade (Grade I: 70.3% vs. 20.5%, p < 0.001) and presented more frequently at Stage I (85.1% vs. 39.8%, p < 0.001). Adjuvant chemotherapy was administered significantly less often in the IPC group than in the IDC group (62.9% vs. 94.9%, p < 0.001). In stage‐specific analyses of Stage I disease, IPC exhibited favourable 5‐year disease‐free survival (81% vs. 69%, p = 0.008) and 5‐year overall survival (85% vs. 75%, p = 0.001) compared with Stage I IDC. Conclusion IPC is a rare tumour type that presents unique clinicopathological characteristics and is associated with a higher rate of breast‐conserving surgery and a favourable prognosis than IDC.
Authors
- Masoumeh Ghoddusi Johari (ORCID: https://orcid.org/0000-0003-3486-7182)
- Mehdi Shariat (ORCID: https://orcid.org/0000-0002-7540-9172)
- Ali Ghaeini Hesarooeih
- Aliyeh Ranjbar (ORCID: https://orcid.org/0000-0002-8897-9684)
- Vahid Zangouri (ORCID: https://orcid.org/0000-0002-6749-6755)
- Maral Mokhtari (ORCID: https://orcid.org/0000-0002-4815-2631)
- Payam Nozad
- Souzan Soufizadeh Balaneji (ORCID: https://orcid.org/0000-0002-2691-1860)
- Negin Nourinejad
- Seyed Amin Mousavi (ORCID: https://orcid.org/0000-0001-9357-0413)
- Morteza Amestejani (ORCID: https://orcid.org/0000-0001-8851-8549)
Institutions
- Shiraz University of Medical Sciences (IR)
- Urmia University (IR)
- Islamic Azad University of Urmia (IR)
- Urmia University of Medical Sciences (IR)
Publication Details
- Journal
- Surgical Practice
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1111/1744-1633.70114
- Primary Topic
- Breast Lesions and Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shiraz University of Medical Sciences